Latest Carcinoid Stories
Top-Line Results Expected in the 3rd Quarter of 2015 THE WOODLANDS, Texas, March 9, 2015 /PRNewswire/ -- Lexicon
Somatuline® is the first and only antitumor therapy demonstrating a statistically significant progression-free survival benefit in a combined population of patients with gastrointestinal
- Results show 94% of patients made lifestyle modifications as a result of their NET, including changes to diet, work, physical activities and social life(1) EAST HANOVER, N.J., Nov.
-- Telotristat etiprate, a Phase 3 compound for the treatment of carcinoid syndrome PARIS and THE WOODLANDS, Texas, Oct.
BerriHealth continues to support research for the neuroendocrine tumor and carcinoid cancer community. Portland, Oregon (PRWEB) February 21, 2014 BerriHealth,
From Patient to Survivor: Author’s Medical Background and Own Cancer Experience Provides Insight and Inspiration for Rare Type of Cancer San Francisco (PRWEB)
DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/q8l6jf/lexicons) has announced the addition of the "Lexicon's
BerriProducts LLC, an Oregon-based supplier of premium quality black raspberry products shares news from the recently-attended Berry Health Benefits Symposium on angiogenesis inhibition with an
The Philly NETs (neuroendocrine tumor cancers) and its patient community will celebrate the 3rd annual worldwide NET Cancer Awareness Day on November 10th at the Philadelphia Zoo with its inaugural
- A serpent whose bite was fabled to produce intense thirst.